Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.72% |
| 2 | Healthcare | 2.38% |
| 3 | Financials | 2.3% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $8.47M | ﹤0.01% |
84,593
-163,047
| -66% | -$16.5M |
|
3127
CALL
BioCryst Pharmaceuticals
BCRX
$2.4B
| $8.47M | ﹤0.01% |
520,700
-299,200
| -36% | -$4.8M |
|
3128
H&R Block
HRB
$5.86B
| $8.47M | ﹤0.01% |
325,154
+84,609
| +35% | +$2.05M |
|
|
COOP
3129
CALL
DELISTED
Mr. Cooper
COOP
| $8.46M | ﹤0.01% |
185,300
+57,500
| +45% | +$2.61M |
|
3130
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| $8.46M | ﹤0.01% |
187,266
-8,798,244
| -98% | -$415M |
|
|
ABMD
3131
CALL
DELISTED
Abiomed Inc
ABMD
| $8.45M | ﹤0.01% |
25,500
-42,900
| -63% | -$13.2M |
|
3132
PUT
FMC
FMC
$1.33B
| $8.43M | ﹤0.01% |
64,100
-181,500
| -74% | -$21.3M |
|
3133
Acushnet Holdings
GOLF
$5.45B
| $8.43M | ﹤0.01% |
209,493
+153,824
| +276% | +$6.95M |
|
3134
BorgWarner
BWA
$13.9B
| $8.43M | ﹤0.01% |
246,217
-190,844
| -44% | -$7.13M |
|
|
NKLA
3135
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $8.42M | ﹤0.01% |
26,217
-13,836
| -35% | -$3.53M |
|
3136
CALL
Organon & Co
OGN
$3.57B
| $8.42M | ﹤0.01% |
240,930
-141,130
| -37% | -$4.83M |
|
|
AIMC
3137
DELISTED
Altra Industrial Motion Corp
AIMC
| $8.41M | ﹤0.01% |
216,008
+103,874
| +93% | +$4.67M |
|
3138
Castle Biosciences
CSTL
$979M
| $8.39M | ﹤0.01% |
187,007
+89,121
| +91% | +$3.68M |
|
|
CFFS
3139
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $8.39M | ﹤0.01% |
+844,754
| New | +$8.37M |
|
3140
Ocular Therapeutix
OCUL
$2.02B
| $8.38M | ﹤0.01% |
1,692,336
+161,314
| +11% | +$894K |
|
3141
Vanguard Morningstar Growth ETF
VUG
$231B
| $8.38M | ﹤0.01% |
174,720
+71,298
| +69% | +$3.37M |
|
|
HOLX
3142
CALL
DELISTED
Hologic
HOLX
| $8.37M | ﹤0.01% |
109,000
-30,900
| -22% | -$2.22M |
|
3143
CALL
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$531M
| $8.37M | ﹤0.01% |
109,000
-85,520
| -44% | -$5.66M |
|
3144
MSC Industrial Direct
MSM
$6.86B
| $8.37M | ﹤0.01% |
98,188
+62,863
| +178% | +$5.09M |
|
3145
Invesco Senior Loan ETF
BKLN
$6.81B
| $8.35M | ﹤0.01% |
383,597
+365,221
| +1,987% | +$7.98M |
|
3146
PUT
Canadian Pacific Kansas City
CP
$80.5B
| $8.35M | ﹤0.01% |
101,104
-132,848
| -57% | -$9.99M |
|
3147
Scotiabank
BNS
$108B
| $8.34M | ﹤0.01% |
116,321
-138,393
| -54% | -$10M |
|
3148
PUT
Scorpio Tankers
STNG
$3.81B
| $8.33M | ﹤0.01% |
389,800
-10,400
| -3% | -$166K |
|
3149
CALL
Tapestry
TPR
$32.8B
| $8.33M | ﹤0.01% |
224,300
-41,900
| -16% | -$1.61M |
|
|
SDAC
3150
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
| $8.33M | ﹤0.01% |
850,750
-512
| -0.1% | -$4.99K |
|
Similar funds
Citadel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
- Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.